Animal studies have identified endocrine disrupting chemicals as potential, albeit unproven, contributors to human disorders, especially to those with fetal origins. These disorders can be detected early if pediatricians are vigilant. Recent evidence for population-level changes in young men and girls, which involve developmental endocrine alterations, underscores the urgency for action.
Concerns about endocrine disrupting chemi cals (EDCs) have come from extensive wild life and animal experimental studies.
1 These studies showed that fetal exposure to EDC mixtures, at doses at which indivi dual chemi cals are ineffective, can cause profound life long adverse effects. Similar detailed studies in humans are few, and evidence on whether EDCs contribute to human health disorders is consequently uncertain.
1,2 If such effects occur in humans, pediatricians and/or neo natologists would be the first to see their evidence-but to see, one has to actively look. The pediatric endocrinology societies on both sides of the Atlantic have, therefore, issued a joint statement in which they alert their members to the possibility that dis orders in some pediatric patients might result from exposure to EDCs.
2 In this statement, Skakkebaek et al. argue that human exposure to individual EDCs, although generally low, is widespread, involves numerous compounds and could underlie some common pediatric disorders, for example, reproductive dis orders such as cryptorchidism in male neo nates and precocious puberty in girls. Both disorders carry longterm health sequelae for affected indivi duals, as is the case with most endocrinebased disorders.
Two issues are fundamental. First, how impor tant are disorders in the population that result from perturbation of endocrine systems? Second, are these disorders actu ally caused by exposure to EDCs, or not? The first is a disturbingly easy question to answer, because disorders involving endocrine disrup tion are very common. Although the obesity and diabetes epi demics spring most readily to mind, these are likely to have nonEDC related explanations. Instead, what about a disorder in young men that is more com mon than type 2 diabetes mellitus? Low sperm count affects one in six young men across Northern Europe today, whereas sperm counts were much higher 60 years ago.
3 Surprisingly, this finding is relevant to pediatricians; in early 2011, two US studies pro vided the first evi dence that low sperm counts and infertility in men originate in fetal life.
4,5
The studies demonstrated a strong relation ship between anogenital distance and sperm counts in young men from the normal popu lation 4 and in men with infer tility and fertile controls;
5 both studies showed that men with low sperm counts had significantly shorter ano genital distance than did those with high sperm counts, and childless men had a sig nificantly shorter anogenital distance than did fathers.
5 Animal studies have shown that ano genital distance provides a lifelong read out of an individual's exposure to androgens during the socalled 'masculiniza tion pro gramming window' (MPW), the critical fetal period when founda tions for subsequent masculiniza tion and normal male reproduc tive develop ment are laid.
6 Insufficient andro gen exposure in the MPW, which can occur, for example, as the result of EDC exposure, 1, 7 leads to smaller adult reproductive organ size (testes, prostate, seminal vesicles, penis) and increased risk of reproductive dis orders (cryptor chidism, hypospadias), as well as a reduced anogenital distance.
6,7 Similar relation ships between anogenital distance and reproductive dis orders are being found in humans, 8, 9 in whom the predicted MPW occurs at 8-14 weeks of gestation.
6
The emerging view is that of a novel tier of 'masculinization disorders' , which mani fest in otherwise normally virilized indivi duals; these changes are much milder than overt dis orders of sexual differentiation (DSDs). At their mildest, these alterations result in small testes size and consequently lower sperm production and sperm counts. Beyond these disorders, a continuum prob ably exists-through cryptorchidism to hypospadias to DSDs-with increasing severity of 'insufficient' masculinization (and shorter anogenital distance).
Anogenital distance is measurable at birth 6, 8, 9 and provides information on fetal events in the MPW, 6 but animal studies also suggest that it provides a forecast of future adultonset disorders such as low sperm counts 6,7 and, more speculatively, perhaps even the risk of testicular germ cell cancer (TGCT). TGCT is the most common cancer in young men, with a peak incidence at ~25 years of age, and its incidence has increased progres sively across Northern Europe over the past Whilst in boys fertility appears to be under threat, girls face different challenges, with evidence from the USA and Europe sug gesting a move towards a younger age at the start of puberty (breast development) at the popu la tion level over the past ~15 years.
10
Such changes cannot be explained by endo genous estrogen levels, which brings me back to my second question. What part, if any, do EDCs play in this change in girls and the emerging events in boys outlined above, because fetuses and children are undoubtedly exposed to EDCs? 1,3 Are (weak) estrogenic EDCs to blame in girls and antiandrogenic EDCs in boys?
The simple answer to these questions is: we do not know. Experimental evidence from animals supports the possible involvement of EDCs, but direct evidence in humans is limited, 1,3 especially for populationlevel effects of the sort that would affect puberty in girls or low sperm counts in men. This response may seem reassuring, but con sider for one moment the difficulty in trying to establish whether low sperm count in a young man is the result of EDC exposure of his mother during pregnancy a quarter of a century earlier. Scenarios such as this one have prompted Skakkebaek et al.'s call to action for pediatricians, who work at the 'information interface' between fetal life and childhood development and have the opportunity to spot changes in patients that could alert to endocrine disruption in fetal life, especially in the mild cases highlighted above. If disorders are detected early, the opportunity arises to reflect on the pregnancy to discern events or exposures to EDCs.
But we must not look just in one direction. We know from the obesity and diabetes epi demics what changes in lifestyle can induce via perturbation of endocrine systems, so we must keep an open mind about lifestyle factors visàvis EDC exposures in the dis orders described above. For example, in preco cious puberty, adrenal steroids in res ponse to changing lifestyle stresses in girls might have a role rather than EDCs.
Scientists are all too familiar with the con cept that, until you start looking, you do not see. The call to action by Skakkebaek et al. should raise awareness and thus launch sys tematic and detailed evidence gathering. This approach may, or may not, implicate EDCs in human reproductive disorders, but without hard evidence we will never be able to reach a conclusion one way or the other. 
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